| 000 | 01078 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250518032320.0 | ||
| 264 | 0 | _c20200127 | |
| 008 | 202001s 0 0 eng d | ||
| 022 | _a1759-4766 | ||
| 024 | 7 |
_a10.1038/s41582-019-0178-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBerghoff, Anna S | |
| 245 | 0 | 0 |
_aDoes neoadjuvant anti-PD1 therapy improve glioblastoma outcome? _h[electronic resource] |
| 260 |
_bNature reviews. Neurology _cJun 2019 |
||
| 300 |
_a314-315 p. _bdigital |
||
| 500 | _aPublication Type: News | ||
| 650 | 0 | 4 |
_aAntibodies _xtherapeutic use |
| 650 | 0 | 4 |
_aBrain Neoplasms _ximmunology |
| 650 | 0 | 4 |
_aGlioblastoma _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 |
_aNeoadjuvant Therapy _xmethods |
| 650 | 0 | 4 |
_aProgrammed Cell Death 1 Receptor _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aPreusser, Matthias | |
| 773 | 0 |
_tNature reviews. Neurology _gvol. 15 _gno. 6 _gp. 314-315 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41582-019-0178-0 _zAvailable from publisher's website |
| 999 |
_c29541338 _d29541338 |
||